Presurgical evaluation of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer. Background: Valproic acid (VPA) is a histone deacetylase (HDAC) inhibitor that increases apoptosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results